SOD2 and neoplasm: SIRT3 inhibits tumor growth by activating FOXO3a and the expression of superoxide dismutase 2 (SOD2), thereby reducing the level of reactive oxygen species (ROS)37-39 and negatively regulating the expression of hypoxia inducible factor-1α (HIF-1α)40,41.